What are the early warning signs of myocarditis during the pathway of care?
Yasar Sattar1, Aimen Shafiq2, Sahithi Sharma3
1Department of Cardiology, West Virginia University, Morgantown, WV, USA.
Insights
This review explores myocarditis, an inflammatory heart condition. It highlights the need for better biomarkers to aid in early diagnosis and treatment of myocarditis.
Area of Science:
- Cardiology
- Immunology
Background:
- Myocarditis is heart inflammation leading to potential heart failure and impaired cardiac function.
- Current diagnostic methods like endomyocardial biopsy and imaging are invasive and expensive.
- There is a need for reliable biomarkers for accurate myocarditis diagnosis and prognosis.
Purpose of the Study:
- To review the definition, clinical features, diagnostic markers, imaging, prognosis, and complications of myocarditis.
- To identify reliable, accurate, and prognostically informative biomarkers for myocarditis.
- To provide clinicians with tools for early diagnosis and treatment of myocarditis.
Main Methods:
- Comprehensive literature search of PubMed, Embase, and Cochrane databases.
- Inclusion of articles from inception up to January 1, 2024.
- Review focused on diagnostic and prognostic biomarkers for myocarditis.
Main Results:
- Myocarditis can cause significant cardiac remodeling, fibrosis, and dysfunction.
- Existing diagnostic techniques present limitations in cost and invasiveness.
- Biomarkers are crucial for understanding disease progression and guiding treatment.
Conclusions:
- Developing and adopting novel diagnostic and prognostic biomarkers is essential for myocarditis management.
- Biomarkers can enhance clinical understanding of myocarditis progression.
- Early diagnosis and treatment, facilitated by biomarkers, can improve patient outcomes in myocarditis.
Introduction:
Myocarditis is an inflammatory disease of the myocardial layer of the heart that can be prone to dilation of chambers with presentation as heart failure secondary to dilated cardiomyopathy. Myocarditis can lead to remodeling and fibrosis that can affect the heart's relaxation-lusitropy and chronotropic function. The current techniques for identifying myocarditis, such as endomyocardial biopsy and imaging, are costly, and intrusive. The current literature aims to identify reliable, accurate, and prognostically educative biomarkers of myocarditis.
Areas Covered:
This review covers the definition, clinical features, diagnostic markers, cardiac imaging, prognosis, and complications of myocarditis. PubMed, Embase, and the Cochrane data bank were searched from inception to 1 January 2024 for relevant articles.
Expert Opinion:
By adopting these diagnostic and prognostic biomarkers, clinicians can have a better comprehension of the progression of the disease and provide early diagnosis and treatment for myocarditis.
More Related Videos
Related Concept Videos
Myocarditis II: Clinical features and Diagnostic Tests
Myocarditis IV: Nursing Management
Myocarditis III: Medical Management
Myocarditis I: Introduction
Pericarditis II: Clinical features and Diagnostic Tests
Pericarditis IV: Nursing Management


